Unprecedented pace and partnerships: the story of and lessons learned from one Ebola vaccine program-Reference-Cited by-同舟云学术

Unprecedented pace and partnerships: the story of and lessons learned from one Ebola vaccine program

Published:2018-10-03 Issue:10 Volume:17 Page:913-923
ISSN:1476-0584
Container-title:Expert Review of Vaccines
language:en
Short-container-title:Expert Review of Vaccines

Author:

Gupta Swati B.¹²,Coller Beth-Ann¹,Feinberg Mark¹³

Affiliation:

1. Global Clinical Development, Merck & Co., Inc, Kenilworth, NJ, USA

2. Research Integration & Innovation, International AIDS Vaccine Initiative, New York, NY, USA

3. Executive Office, International AIDS Vaccine Initiative, New York, NY, USA

Funder

Doctors Without Borders

Merck

NewLink Genetics

US Department of Defense

US Department of Health and Human Services

Public Health Agency of Canada

Wellcome Trust

World Health Organization

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,Molecular Medicine,Immunology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14760584.2018.1527692

Reference50 articles.

1. WHO. Ebola Situation Report, 30 March 2016. http://apps.who.int/ebola/current-situation/ebola-situation-report-30-march-2016 [cited 2016 Oct 5].

2. WHO. Statement on the 1st meeting of the IHR Emergency Committee on the 2014 Ebola outbreak in West Africa – WHO statement, 8 August 2014. http://www.who.int/mediacentre/news/statements/2014/ebola-20140808/en/ [cited 2016 Oct 5].

3. Vesicular stomatitis virus-based vaccines protect nonhuman primates against aerosol challenge with Ebola and Marburg viruses

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Improving COVID-19 Vaccine Uptake in Saskatchewan, Canada: A Developmental Evaluation Approach;The Open Public Health Journal;2024-03-21

2. Regulatory processes involved in clinical trials and intellectual property rights around vaccine development;Advanced Vaccination Technologies for Infectious and Chronic Diseases;2024

3. A Short History of Vaccination;Plotkin's Vaccines;2023

4. Nonhuman Primates Are Protected against Marburg Virus Disease by Vaccination with a Vesicular Stomatitis Virus Vector-Based Vaccine Prepared under Conditions to Allow Advancement to Human Clinical Trials;Vaccines;2022-09-21

5. A critical review of public–private partnerships in the COVID-19 pandemic: key themes and future research agenda;Smart and Sustainable Built Environment;2022-04-19